FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes

Grunberger Diabetes Institute Diabetes, Diabetes Medications FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes
0 Comments

Click here for the article posted by Lisa Nainggolan on Medscape.

Categories:

1 thought on “FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes”

  1. torrent says:

    Wonderful post! We are linking to this great post on our site. Leanna Martie Ulrika

Comments are closed.

Related Posts

What to Know About Zegalogue: A new glucagon rescue
Patients whose diabetes treatment includes insulin will experience hypoglycemic episodes, which occur when most people’s
How to Diagnose a Thyroid Condition
January is Thyroid Awareness Month, so it is only fitting we release an article with
Gvoke: Ready-to-Use Glucagon Pen
Low blood sugar, referred to as hypoglycemia, can be a concerning thought for individuals with